JGC
ZBH icon

J. Goldman & Co’s Zimmer Biomet ZBH Stock Holding History

J. Goldman & Co’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-17,840
Closed -$2.07M – 400
2020
Q2 		$2.07M Buy
+17,840
New +$2.06M 0.13% 154
2020
Q1 		– Sell
-78,313
Closed -$11.4M – 357
2019
Q4 		$11.4M Sell
78,313
-9,290
-11% -$1.28M 0.82% 29
2019
Q3 		$11.7M Buy
87,603
+20,868
+31% +$2.7M 0.88% 32
2019
Q2 		$7.63M Sell
66,735
-58,263
-47% -$6.82M 0.53% 66
2019
Q1 		$15.5M Buy
+124,998
New +$14.2M 0.87% 28
2016
Q1 		– Sell
-55,783
Closed -$5.56M – 369
2015
Q4 		$5.56M Buy
+55,783
New +$5.46M 0.57% 62
2015
Q2 		– Sell
-18,764
Closed -$2.14M – 344
2015
Q1 		$2.14M Buy
+18,764
New +$2.14M 0.13% 180
2013
Q4 		– Sell
-12,360
Closed -$986K – 303
2013
Q3 		$986K Buy
+12,360
New +$973K 0.09% 197

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

J. Goldman & Co's ZBH Position: Q3 2020 in Review

J. Goldman & Co sold out of Zimmer Biomet (ZBH) in Q3 2020, closing a stake of 17,840 shares — an estimated $2.07M sold.

J. Goldman & Co first reported a position in ZBH in Q3 2013 and held it in 8 quarters. The position peaked at $15.5M in Q1 2019. 930 funds tracked by Wall St. Rank hold ZBH as of Q3 2020.

  • J. Goldman & Co reported no remaining Zimmer Biomet position as of Q3 2020 after selling out during the quarter.
  • J. Goldman & Co sold 17,840 Zimmer Biomet shares in Q3 2020, an estimated $2.07M.
  • J. Goldman & Co first reported a position in Zimmer Biomet in Q3 2013 and held it in 8 quarters.
  • J. Goldman & Co's Zimmer Biomet position peaked at $15.5M in Q1 2019.
  • 930 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2020.

Based on J. Goldman & Co's 13F filing for Q3 2020, filed 16 Nov 2020.